Upstream Total Assets vs Capital Lease Obligations Analysis
| UPB Stock | 19.19 0.26 1.34% |
Upstream Bio, financial indicator trend analysis is much more than just breaking down Upstream Bio, prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Upstream Bio, is a good investment. Please check the relationship between Upstream Bio, Total Assets and its Capital Lease Obligations accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Upstream Bio,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.
Total Assets vs Capital Lease Obligations
Total Assets vs Capital Lease Obligations Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Upstream Bio, Total Assets account and Capital Lease Obligations. At this time, the significance of the direction appears to have pay attention.
The correlation between Upstream Bio,'s Total Assets and Capital Lease Obligations is -0.99. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Capital Lease Obligations in the same time period over historical financial statements of Upstream Bio,, assuming nothing else is changed. The correlation between historical values of Upstream Bio,'s Total Assets and Capital Lease Obligations is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Upstream Bio, are associated (or correlated) with its Capital Lease Obligations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Lease Obligations has no effect on the direction of Total Assets i.e., Upstream Bio,'s Total Assets and Capital Lease Obligations go up and down completely randomly.
Correlation Coefficient | -0.99 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Total Assets
Total assets refers to the total amount of Upstream Bio, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Upstream Bio, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Capital Lease Obligations
Upstream Bio, capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Upstream Bio, asset purchases. For example, Upstream Bio, can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Upstream Bio, control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Most indicators from Upstream Bio,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Upstream Bio, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Upstream Bio,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.As of December 28, 2024, Selling General Administrative is expected to decline to about 9.4 M. In addition to that, Issuance Of Capital Stock is expected to decline to about 76.7 M
| 2010 | 2023 | 2024 (projected) | Interest Income | 205K | 4.2M | 2.4M | Net Interest Income | 205K | 4.2M | 2.4M |
Upstream Bio, fundamental ratios Correlations
Click cells to compare fundamentals
Upstream Bio, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Upstream Bio, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Upstream Bio,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Upstream Bio, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Upstream Bio, Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Upstream Bio,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio,. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Upstream Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Upstream Bio, is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio,'s market value can be influenced by many factors that don't directly affect Upstream Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Upstream Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Upstream Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.